This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

The Need for Luteal Support in NC-FET

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2014 by Wolfson Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Wolfson Medical Center
ClinicalTrials.gov Identifier:
NCT01483365
First received: November 29, 2011
Last updated: June 15, 2014
Last verified: June 2014
November 29, 2011
June 15, 2014
December 2011
December 2014   (Final data collection date for primary outcome measure)
Pregnancy rate [ Time Frame: 4 weeks ]
We would like to investigate whether there is need for luteal support in NC-FET cycle.
Same as current
Complete list of historical versions of study NCT01483365 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Need for Luteal Support in NC-FET
The Use of Luteal Support After NC-FET
The investigators are going to examine prospectively the need of luteal support after NC-FET.
The investigators are going to examine retroprospectively the need of luteal support after NC-FET in IVF cycle. One arm will receive luteal support after NC FET with vaginal tablet of Endometrin 100 mg twice a day after ET. The second arm will not. We are going to evaluate the pregnancy and implantation rate.
Interventional
Early Phase 1
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Abnormal Menstrual Cycle
Drug: Vaginal tablet Endometrin twice a day
Endometrin 100 mg twice a day
Other Name: Endometrin 100 mg twice a day
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
100
December 2014
December 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women under 39 years old, regular menstruation going through IVF NC-FET

Exclusion Criteria:

Sexes Eligible for Study: Female
18 Years to 39 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT01483365
0087-11-WOMC-
Yes
Not Provided
Not Provided
Not Provided
Wolfson Medical Center
Wolfson Medical Center
Not Provided
Principal Investigator: David Levran, M.D IVF Unit, Department of Obstetrics and Gynecology,Wolfson Medical Center . Holon, Israel
Wolfson Medical Center
June 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP